Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Fortress Biotech Inc.

    NASDAQ: FBIO · Real-Time Price · USD
    1.89
    0.04 (2.16%)
    At close: Jun 05, 2025, 3:59 PM
    1.90
    0.71%
    After-hours: Jun 05, 2025, 07:16 PM EDT

    Fortress Biotech Statistics

    Share Statistics

    Fortress Biotech has 29.57M shares outstanding. The number of shares has increased by 35.24% in one year.

    Shares Outstanding

    n/a
    		 29.57M

    Shares Change (YoY)

    n/a
    		 35.24%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 23.06%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 25,748

    FTD / Avg. Volume

    n/a
    		 10.69%

    Short Selling Information

    The latest short interest is 3.51M, so 11.87% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.51M

    Short % of Shares Out

    n/a
    		 11.87%

    Short % of Float

    n/a
    		 15.04%

    Short Ratio (days to cover)

    n/a
    		 25.24

    Valuation Ratios

    The PE ratio is -0.92 and the forward PE ratio is -2.25. Fortress Biotech's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.92

    Forward PE

    n/a
    		 -2.25

    PS Ratio

    n/a
    		 0.73

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 1.86

    P/FCF Ratio

    n/a
    		 -0.44

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Fortress Biotech.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.27, with a Debt / Equity ratio of 3.34.

    Current Ratio

    n/a
    		 1.27

    Quick Ratio

    n/a
    		 1.06

    Debt / Equity

    n/a
    		 3.34

    Debt / EBITDA

    n/a
    		 -0.73

    Debt / FCF

    n/a
    		 -0.8

    Interest Coverage

    n/a
    		 -9.53

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $571,039.6

    Profits Per Employee

    n/a
    		 $-455,415.84

    Employee Count

    n/a
    		 101

    Asset Turnover

    n/a
    		 0.4

    Inventory Turnover

    n/a
    		 1.45

    Taxes

    Income Tax

    n/a
    		 312K

    Effective Tax Rate

    n/a
    		 -0.26%

    Stock Price Statistics

    The stock price has increased by 2.17% in the last 52 weeks. The beta is 1.77, so Fortress Biotech's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.77

    52-Week Price Change

    n/a
    		 2.17%

    50-Day Moving Average

    n/a
    		 1.67

    200-Day Moving Average

    n/a
    		 1.77

    Relative Strength Index (RSI)

    n/a
    		 57.2

    Average Volume (20 Days)

    n/a
    		 240,882

    Income Statement

    In the last 12 months, Fortress Biotech had revenue of 57.67M and earned -46M in profits. Earnings per share was -2.21.

    Revenue

    n/a
    		 57.67M

    Gross Profit

    n/a
    		 36.8M

    Operating Income

    n/a
    		 -110.38M

    Net Income

    n/a
    		 -46M

    EBITDA

    n/a
    		 -104.49M

    EBIT

    n/a
    		 -108.95M

    Earnings Per Share (EPS)

    n/a
    		 -2.21
    Full Income Statement

    Balance Sheet

    The company has 57.26M in cash and 75.96M in debt, giving a net cash position of -18.7M.

    Cash & Cash Equivalents

    n/a
    		 57.26M

    Total Debt

    n/a
    		 75.96M

    Net Cash

    n/a
    		 -18.7M

    Retained Earnings

    n/a
    		 -740.87M

    Total Assets

    n/a
    		 178.07M

    Working Capital

    n/a
    		 53.23M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -80.19M and capital expenditures -15M, giving a free cash flow of -95.19M.

    Operating Cash Flow

    n/a
    		 -80.19M

    Capital Expenditures

    n/a
    		 -15M

    Free Cash Flow

    n/a
    		 -95.19M

    FCF Per Share

    n/a
    		 -4.58
    Full Cash Flow Statement

    Margins

    Gross margin is 63.8%, with operating and profit margins of -191.38% and -79.75%.

    Gross Margin

    n/a
    		 63.8%

    Operating Margin

    n/a
    		 -191.38%

    Pretax Margin

    n/a
    		 -209%

    Profit Margin

    n/a
    		 -79.75%

    EBITDA Margin

    n/a
    		 -181.17%

    EBIT Margin

    n/a
    		 -191.38%

    FCF Margin

    n/a
    		 -165.05%

    Dividends & Yields

    FBIO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for FBIO is $21, which is 1017% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $21

    Price Target Difference

    n/a
    		 1017%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 10, 2023. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Oct 10, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -6.71

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist